Abstract

BackgroundThe coronavirus disease 2019 (COVID-19) is a pandemic now, and the severity of COVID-19 determines the management, treatment, and even prognosis. We aim to develop and validate a radiomics nomogram for identifying patients with severe COVID-19.MethodsThere were 156 and 104 patients with COVID-19 enrolled in primary and validation cohorts, respectively. Radiomics features were extracted from chest CT images. Least absolute shrinkage and selection operator (LASSO) method was used for feature selection and radiomics signature building. Multivariable logistic regression analysis was used to develop a predictive model, and the radiomics signature, abnormal WBC counts, and comorbidity were incorporated and presented as a radiomics nomogram. The performance of the nomogram was assessed through its calibration, discrimination, and clinical usefulness.ResultsThe radiomics signature consisting of four selected features was significantly associated with clinical condition of patients with COVID-19 in the primary and validation cohorts (P < 0.001). The radiomics nomogram including radiomics signature, comorbidity and abnormal WBC counts showed good discrimination of severe COVID-19, with an AUC of 0.972, and good calibration in the primary cohort. Application of the nomogram in the validation cohort still gave good discrimination with an AUC of 0.978 and good calibration. Decision curve analysis demonstrated that the radiomics nomogram was clinically useful to identify the severe COVID-19.ConclusionWe present an easy-to-use radiomics nomogram to identify the patients with severe COVID-19 for better guiding a prompt management and treatment.

Highlights

  • The coronavirus disease 2019 (COVID-19) is a pandemic and the severity of COVID-19 determines the management, treatment, and even prognosis

  • It was reported that the computed tomography (CT) features of COVID-19 was manifested as patchy groundglass opacities (GGOs) with or without consolidation distributed in subpleural areas of bilateral lungs [11], and increased numbers, greater extent of consolidation on chest CT images were related to progression of COVID-19 [12]

  • In this study, we developed and validated a radiomics nomogram based on the quantitation of lung abnormalities on CT images caused by COVID-19 to identify the severe patients for guiding a prompt management and treatment

Read more

Summary

Introduction

The coronavirus disease 2019 (COVID-19) is a pandemic and the severity of COVID-19 determines the management, treatment, and even prognosis. It was reported that the CT features of COVID-19 was manifested as patchy groundglass opacities (GGOs) with or without consolidation distributed in subpleural areas of bilateral lungs [11], and increased numbers, greater extent of consolidation on chest CT images were related to progression of COVID-19 [12]. These studies were limited to qualitative analysis, merely focusing on the manifestation of COVID-19 on chest CT images to screen potential new cases of COVID-19. Baratella et al [13] used a semi-quantitative score of chest X-ray to assess the severity of lung involvement in COVID19 patients. The quantitative analysis of correlation between pulmonary abnormalities of COVID-19 on chest CT images and the clinical severity or condition of COVID19 has not been investigated thoroughly, which may be promising for improving the management of COVID-19

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call